Items 61 to 80 of 149 total

per page
Page:
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6

Set Ascending Direction
    Cat. No. Name CAS No. Description
    KI4147 NVP-BHG712 940310-85-0 ....
    KI1334 NVP-AEW541 475489-16-8 NVP-AEW541 is a novel, potent, and selective inhibitor of the IGF-IR kinase....
    KI3430 NVP-ADW742 475488-23-4 NVP-ADW742 is a small molecule ATP-competitive inhibitor of the IGF-I receptor (IGF-IR) with an IC50 of 0.17 µM....
    KI2103 NSC 87877 56990-57-9 NSC 87877 is a potent inhibitor of shp2 and shp1 protein tyrosine phosphatases (PTP)....
    KI0289 Nilotinib 641571-10-0 Nilotinib inhibits the kinases BCR-ABL, KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK....
    KI0084 Neratinib 698387-09-6 Neratinib is a dual inhibitor of the human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR) kinases....
    KI4363 Nelarabine 121032-29-9 ....
    KI0275 MP-470 850879-09-03 MP-470 is a novel orally bioavailable mutitargeting tyrosine kinase inhibitor with activity against mutant c-KIT, PDGFRa and FLT3....
    KI4665 Motesanib 453562-69-1 ....
    KI2821 MK-8033 1196681-38-5 MK-8033 is a dual c-Met/Ron inhibitor....
    KI4704 MK-2461 917879-39-1 ....
    KI1359 Masitinib 790299-79-5 Masitinib is a potent and selective inhibitor of KIT....
    KI4071 LY2811376 1194044-20-6 ....
    KI1453 LY2801653 1206799-15-6 LY2801653 is a type-II ATP competitive, slow-off inhibitor of MET tyrosine kinase....
    KI0380 LY2784544 1229236-86-5 LY2784544 has been identified as being highly selective for JAK 2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders....
    KI0047 Linifanib 796967-16-3 Linifanib is a receptor tyrosine kinase (RTK) inhibitor....
    KI1019 Lestaurtinib 111358-88-4 Lestaurtinib is a potent and orally available fms-like kinase (FLT3) inhibitor....
    KI4179 LDK378 1032900-25-6 ....
    KI0431 Lapatinib 231277-92-2 Lapatinib is a selective inhibitor of both epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases with IC50 of 10.2 and 9.8 nM, respectively....
    KI3335 KRN 633 286370-15-8 KRN 633 is a novel quinazoline urea derivative and a potent ATP-competitive inhibitor of VEGFR-1, -2 and -3 with IC50s of 170, 160, and 125 nM, respectively....

Items 61 to 80 of 149 total

per page
Page:
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6

Set Ascending Direction